American Journal of Transplantation

Article	Citations
OPTN/SRTR 2019 Annual Data Report: Kidney	296
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium	295
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus	275
OPTN/SRTR 2019 Annual Data Report: Liver	250
OPTN/SRTR 2020 Annual Data Report: Liver	246
First clinical-grade porcine kidney xenotransplant using a human decedent model	241
OPTN/SRTR 2020 Annual Data Report: Kidney	236
Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020	226
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients	199
Is COVID-19 infection more severe in kidney transplant recipients?	192
COVID-19 in transplant recipients: The Spanish experience	139
OPTN/SRTR 2019 Annual Data Report: Lung	132
SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study	126
OPTN/SRTR 2021 Annual Data Report: Kidney	126
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients	124
OPTN/SRTR 2020 Annual Data Report: Heart	122
Long-term kidney transplant graft survival—Making progress when most needed	121
OPTN/SRTR 2021 Annual Data Report: Liver	119
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients	115
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing	114
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study	113
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients	108
Impact of COVID-19 in solid organ transplant recipients	106
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	102
COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020	100

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients	99
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss	97
OPTN/SRTR 2019 Annual Data Report: Heart	95
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave	93
PD-1 inhibitor as bridge therapy to liver transplantation?	89
Ten years of donor-derived disease: A report of the disease transmission advisory committee	87
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept	87
Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients	86
OPTN/SRTR 2020 Annual Data Report: Lung	85
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States	85
A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned	84
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients	82
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients	78
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement	78
Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques	78
Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study	78
Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers	74
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience	74
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes	72
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients	71
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial	69
Use of tocilizumab in kidney transplant recipients with COVID-19	68
OPTN/SRTR 2021 Annual Data Report: Lung	67
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine	66
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients	66
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination	65
Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study	64
Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge	64
Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: A report of 10 cases	62
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic	62
Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation	60
In-depth virological assessment of kidney transplant recipients with COVID-19	60
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients	60
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action	60
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients	60
Consensus conference on heart-kidney transplantation	59
COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities	59
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients	58
Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort	58
Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants	58
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency	57
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients	57
Organ donation during the COVID-19 pandemic	57
COVID-19 in lung transplant recipients: A single center case series from New York City	56
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping?	56
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021	56
Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic	56
Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion	55
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients	55
COVID-19 in lung transplant recipients: A multicenter study	55

Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation	53
Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States	52
First World Consensus Conference on pancreas transplantation: Part II – recommendations	52
Greater complexity and monitoring of the new Kidney Allocation System: Implications and unintended consequences of concentric circle kidney allocation on network complexity	52
Spanish experience with heart transplants from controlled donation after the circulatory determination of death using thoraco-abdominal normothermic regional perfusion and cold storage	51
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement	51
Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors	50
Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation	50
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study	50
Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry	49
Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: A European observational cohort study	49
Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation	49
Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in transplantation	49
Normothermic kidney perfusion: An overview of protocols and strategies	49
A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donors	49
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation	48
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma	48
The negative impact of T cell–mediated rejection on renal allograft survival in the modern era	48
Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?	48
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept	48
Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection	47
OPTN/SRTR 2020 Annual Data Report: Pancreas	47
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients	47
CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder	46
SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients	46
OPTN/SRTR 2019 Annual Data Report: Pancreas	46
Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes	46
Dismantling structural racism as a root cause of racial disparities in COVID-19 and transplantation	46
Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study	46
Response to American College of Physician’s statement on the ethics of transplant after normothermic regional perfusion	45
White paper on antimicrobial stewardship in solid organ transplant recipients	45
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients	44
Early liver transplantation after COVID-19 infection: The first report	44
Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial	44
Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region	44
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection	44
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic	44
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients	43
Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys	43
Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient	43
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study	43
Cyclosporine and COVID-19: Risk or favorable?	42
Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab	42
Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic	42
Cytokine absorption during human kidney perfusion reduces delayed graft function–associated inflammatory gene signature	42
Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients	42
Normothermic regional perfusion and US legal standards for determining death are not aligned	41
The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era	41
Navigating the COVID-19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States	40
Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic	40
Guidelines for standardized nomenclature and reporting in uterus transplantation: An opinion from the United States Uterus Transplant Consortium	40
Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation	40
COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era	40
American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement	40
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative	40
Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine — United States, December 21, 2020–January 10, 2021	39
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor	39
Extracellular vesicles for treatment of solid organ ischemia–reperfusion injury	39
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring	38
Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine — United States, December 14–23, 2020	38
MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis	38
Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients	38
Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection	38
Racial disparities in preemptive waitlisting and deceased donor kidney transplantation: Ethics and solutions	38
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation	38
Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort	37
Imlifidase for the treatment of anti-HLA antibody-mediated processes in kidney transplantation	37
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic	36
Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members — Chicago, Illinois, December 2020–March 2021	36
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept	36
OPTN/SRTR 2021 Annual Data Report: Heart	36
Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences	36
Expected effect of the lung Composite Allocation Score system on US lung transplantation	35
Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States	35
An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients	35
Cost-utility analysis of normothermic machine perfusion compared to static cold storage in liver transplantation in the Canadian setting	35
Successful orthotopic liver transplantation in a patient with a positive SARS-CoV2 test and acute liver failure secondary to acetaminophen overdose	35
Effect of delayed graft function on longer-term outcomes after kidney transplantation from donation after circulatory death donors in the United Kingdom: A national cohort study	34
Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients	34
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study	34

Robotic donor hepatectomy: A major breakthrough in living donor liver transplantation	34
Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients	34
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV	34
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics	34
COVID-19 in lung transplant patients: A case series	34
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19	34
Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document	33
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update	33
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely	33
Ethical review of COVID-19 vaccination requirements for transplant center staff and patients	33
Frailty and aging-associated syndromes in lung transplant candidates and recipients	33
Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy	32
OPTN/SRTR 2019 Annual Data Report: Intestine	32
Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era	32
Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity	32
Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses	32
The kidney evaluation of living kidney donor candidates: US practices in 2017	31
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?	31
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy	31
Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics	31
Pure laparoscopic living donor liver transplantation: Dreams come true	31
The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients	31
Effect of nirmatrelvir/ritonavir on calcineurin inhibitor levels: Early experience in four SARS-CoV-2 infected kidney transplant recipients	31
Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients—Results from a proof-of-concept study	30
Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: A porcine renal autotransplantation study	30
Characterizing the landscape and impact of infections following kidney transplantation	30
Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada	30
The impact of multi-organ transplant allocation priority on waitlisted kidney transplant candidates	30
Organ transplantation using COVID-19-positive deceased donors	30
Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients	29
Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants	29
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial	29
Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities	29
Impact of hospital strain on excess deaths during the COVID-19 pandemic—United States, july 2020–july 2021	29
Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers	29
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients	29
T cell antigenicity and immunogenicity of allogeneic exosomes	29
Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients	29
The first increase in live kidney donation in the United States in 15 years	29
Single-stage long-segment tracheal transplantation	29
COVID-19 in solid organ transplant recipients: A national cohort study from Sweden	29
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients	29
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study	29
Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States	28
OPTN/SRTR 2020 Annual Data Report: Intestine	28
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition	28
Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival	28
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	28
The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury	28
The Fourth International Workshop on Clinical Transplant Tolerance	28
Kidney nonprocurement in solid organ donors in the United States	27
Full facial retransplantation in a female patient—Technical, immunologic, and clinical considerations	27
Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers	27
Renal infarct in a COVID-19–positive kidney–pancreas transplant recipient	27
Lung transplantation for acute respiratory distress syndrome: A multicenter experience	27
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study	27
Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation	27
OPTN/SRTR 2019 Annual Data Report: Deceased Organ Donors	27
Impact of donor extracellular vesicle release on recipient cell “cross-dressing” following clinical liver and kidney transplantation	27
Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study	27
ATC 2023 Poster Abstracts	27
Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: A retrospective multicenter cohort study	27
Six-month abdominal transplant recipient outcomes from donation after circulatory death heart donors: A retrospective analysis by procurement technique	26
OPTN/SRTR 2020 Annual Data Report: Introduction	26
Correcting the sex disparity in MELD-Na	26
Candida auris outbreak involving liver transplant recipients in a surgical intensive care unit	26
Effectiveness of T cell–mediated rejection therapy: A systematic review and meta-analysis	26
Kidney allograft biopsy findings after COVID-19	26
Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR	26
TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury	26
Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion	26
Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells	26
Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis	26
Poster Abstracts	26
Hypothermic, oxygenated perfusion (HOPE) provides cardioprotection via succinate oxidation prior to normothermic perfusion in a rat model of donation after circulatory death (DCD)	25
Critical warm ischemia time point for cardiac donation after circulatory death	25
Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up	25
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)	25
Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient	25
The inhibition of eIF5A hypusination by GC7, a preconditioning protocol to prevent brain death-induced renal injuries in a preclinical porcine kidney transplantation model	25
Successful lung transplantation with graft recovered after thoracoabdominal normothermic perfusion from donor after circulatory death	25
Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature	25
Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report	25
Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation—A Danish nationwide cohort study	25
Antibody response to 2-dose SARS-CoV-2 mRNA vaccination in pediatric solid organ transplant recipients	25
Pig-to-baboon lung xenotransplantation: Extended survival with targeted genetic modifications and pharmacologic treatments	25
Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change	24
Intragraft gene expression in native kidney BK virus nephropathy versus T cell–mediated rejection: Prospects for molecular diagnosis and risk prediction	24
Induction of ferroptosis selectively eliminates senescent tubular cells	24
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction	24
OPTN/SRTR 2020 Annual Data Report: DOD	24
Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial	24
Extinguishing burnout: National analysis of predictors and effects of burnout in abdominal transplant surgery fellows	24
COVID-19 in recent kidney transplant recipients	24
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients	24